New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
08:02 EDTERBERBA Diagnostics receives 510(K) clearance for XL200 analyzer
ERBA Diagnostics announced that it has received clearance from the U.S. Food and Drug Administration on the 510(k) premarket submission that ERBA Diagnostics had filed for its new clinical chemistry analyzer the XL 200. The XL-200 is a state-of-the-art, random access, clinical chemistry analyzer that can perform up to 400 tests per hour.
News For ERB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
08:13 EDTERBERBA Diagnostics enters Brazilian market
ERBA Diagnostics announced its fully integrated portfolio of in vitro diagnostics platforms and reagents for Hematology and Clinical Chemistry are now available to hospitals, references labs and physician clinics in Brazil. ERBA Diagnostics' product line includes a comprehensive suite of instruments, reagents and kits for immunology, clinical chemistry, hematology, diabetes and infectious disease testing. ERBA Diagnostics intends to introduce its full suite of products to hospitals, references labs and physician clinics in Brazil as the product registrations in Brazil are completed. The estimated market for in vitro diagnostics products in Brazil was approximately $1B 2012 and is expected to grow to $1.4B by 2017, far exceeding the rate of growth in the world market for in vitro diagnostics products.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use